Systemic compensatory response to neonatal estradiol exposure does not prevent depletion of the oocyte pool in the rat

PLoS One. 2013 Dec 16;8(12):e82175. doi: 10.1371/journal.pone.0082175. eCollection 2013.

Abstract

The formation of ovarian follicles is a finely tuned process that takes place within a narrow time-window in rodents. Multiple factors and pathways have been proposed to contribute to the mechanisms triggering this process but the role of endocrine factors, especially estrogens, remains elusive. It is currently hypothesized that removal from the maternal hormonal environment permits follicle formation at birth. However, experimentally-induced maintenance of high 17β-estradiol (E2) levels leads to subtle, distinct, immediate effects on follicle formation and oocyte survival depending on the species and dose. In this study, we examined the immediate effects of neonatal E2 exposure from post-natal day (PND) 0 to PND2 on the whole organism and on ovarian follicle formation in rats. Measurements of plasma E2, estrone and their sulfate conjugates after E2 exposure showed that neonatal female rats rapidly acquire the capability to metabolize and clear excessive E2 levels. Concomitant modifications to the mRNA content of genes encoding selected E2 metabolism enzymes in the liver and the ovary in response to E2 exposure indicate that E2 may modify the neonatal maturation of these organs. In the liver, E2 treatment was associated with lower acquisition of the capability to metabolize E2. In the ovary, E2 depleted the oocyte pool in a dose dependent manner by PND3. In 10 µg/day E2-treated ovaries, apoptotic oocytes were observed in newly formed follicles in addition to areas of ovarian cord remodeling. At PND6, follicles without any visible oocyte were present and multi-oocyte follicles were not observed. Our study reveals a major species-difference. Indeed, neonatal exposure to E2 depletes the oocyte pool in the rat ovary, whereas in the mouse it is well known to increase oocyte survival.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Estradiol / blood
  • Estradiol / pharmacology*
  • Estrone / blood
  • Female
  • Oocytes / drug effects*
  • Oocytes / metabolism
  • Ovarian Follicle / drug effects*
  • Ovarian Follicle / metabolism
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Estrone
  • Estradiol

Grants and funding

C. Chalmey is funded by Region Bretagne (Doctoral research grant #10022). This study was funded by Inserm, University Rennes 1 (Défits scientifiques émergents –2010) and Rennes Metropole (#10–705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.